Aspen Pharmacare says it will make SA’s “single-biggest pharmaceutical investment” when it pours another R3.4bn into its manufacturing facility in Port Elizabeth. The funds would go towards the production of sterile anaesthetics — “a niche, high-tech manufacturing capability that presents both domestic and export opportunities”, Aspen senior executive Stavros Nicolaou said. Nicolaou was speaking at SA’s inaugural investment conference, where President Cyril Ramaphosa aimed to raise funds as part of his plan to get $100bn in new investments into SA. Nicolaou said Ramaphosa’s drive to create “a more predictable, stable investment environment and reducing regulatory burden in key economic sectors, such as the pharmaceutical sector, is very encouraging”. “While Aspen operates manufacturing plants in many geographies, it has chosen SA as the location for its largest and most critical manufacturing facilities.” While Aspen was encouraged by the government’s “investment direction”, a numbe...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, Morningstar financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00.